Hydroxylation of antitubercular drug candidate, SQ109, by mycobacterial cytochrome P450 | bioRxiv
SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis | Antimicrobial Agents and Chemotherapy
SQ109 | Working Group for New TB Drugs
Direct Inhibition of MmpL3 by Novel Antitubercular Compounds | ACS Infectious Diseases
SQ109 mechanism of action The figure depicts stylized components of the... | Download Scientific Diagram
Pharmacokinetics and Target Attainment of SQ109 in Plasma and Human-Like Tuberculosis Lesions in Rabbits | Antimicrobial Agents and Chemotherapy
New agents for the treatment of drug-resistant Mycobacterium tuberculosis - ScienceDirect
Tuberculosis Drugs and Mechanisms of Action | NIH: National Institute of Allergy and Infectious Diseases
IJMS | Free Full-Text | Hydroxylation of Antitubercular Drug Candidate, SQ109, by Mycobacterial Cytochrome P450 | HTML
SQ109 | Infectex
Novel candidates in the clinical development pipeline for TB drug development and their synthetic approaches - Kumar - 2021 - Chemical Biology & Drug Design - Wiley Online Library
SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis | Antimicrobial Agents and Chemotherapy
SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis | Antimicrobial Agents and Chemotherapy
SQ109, a new drug lead for Chagas disease. - Abstract - Europe PMC
Biomedicines | Free Full-Text | In Vivo Efficacy of SQ109 against Leishmania donovani, Trypanosoma spp. and Toxoplasma gondii and In Vitro Activity of SQ109 Metabolites | HTML
Hydroxylation of antitubercular drug candidate, SQ109, by mycobacterial cytochrome P450 | bioRxiv
Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action. | Semantic Scholar
SQ109 tissue levels after oral administration to mice for 28 days SQ109... | Download Scientific Diagram
SQ109 | CAS:502487-67-4 | Antibiotic for treatment of pulmonary T | High Purity | Manufacturer BioCrick
Insights on how the Mycobacterium tuberculosis heme uptake pathway can be used as a drug target | Future Medicinal Chemistry
IJMS | Free Full-Text | Hydroxylation of Antitubercular Drug Candidate, SQ109, by Mycobacterial Cytochrome P450 | HTML
SQ109 mechanism of action The figure depicts stylized components of the... | Download Scientific Diagram
Applied Sciences | Free Full-Text | Mycobacterial Cell Wall: A Source of Successful Targets for Old and New Drugs | HTML
New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects - The Lancet Infectious Diseases
